Standard InChI: InChI=1S/C20H23N3O2S2/c1-19(2)12-20(3,4)27-17-10-7-14(11-16(17)19)22-18(26)21-13-5-8-15(9-6-13)23(24)25/h5-11H,12H2,1-4H3,(H2,21,22,26)
1.Liu S, Brown CW, Berlin KD, Dhar A, Guruswamy S, Brown D, Gardner GJ, Birrer MJ, Benbrook DM.. (2004) Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells., 47 (4):[PMID:14761202][10.1021/jm030346v]
2.Liu S, Louie MC, Rajagopalan V, Zhou G, Ponce E, Nguyen T, Green L.. (2015) Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents., 25 (6):[PMID:25701251][10.1016/j.bmcl.2015.01.042]
3.Gnanasekaran KK, Benbrook DM, Nammalwar B, Thavathiru E, Bunce RA, Berlin KD.. (2015) Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line., 96 [PMID:25880346][10.1016/j.ejmech.2015.03.070]
4.Watts FM, Pouland T, Bunce RA, Berlin KD, Benbrook DM, Mashayekhi M, Bhandari D, Zhou D.. (2018) Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2., 158 [PMID:30245396][10.1016/j.ejmech.2018.09.036]
5.Nammalwar B, Bunce RA, Berlin KD, Benbrook DM, Toal C.. (2019) Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780., 170 [PMID:30878829][10.1016/j.ejmech.2019.03.010]
6.Gnanasekaran KK, Pouland T, Bunce RA, Darrell Berlin K, Abuskhuna S, Bhandari D, Mashayekhi M, Zhou DH, Benbrook DM.. (2020) Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells., 28 (1):[PMID:31831296][10.1016/j.bmc.2019.115244]